Download Common congenital malformations: Name 7

Document related concepts

Infection wikipedia , lookup

Molecular mimicry wikipedia , lookup

African trypanosomiasis wikipedia , lookup

Globalization and disease wikipedia , lookup

Germ theory of disease wikipedia , lookup

Transcript
Amantadine: Mechanism of action of Amantadine.
Blocks viral penetration/uncoating; may buffer pH of endosome. Also causes
the release of dopamine from intact nerve terminals. "Amantadine blocks
influenza A and rubellA and causes problems with the cerebellA."
Amantadine: Clinical uses of Amantadine.
Prophylaxis for influenza A; Parkinson's disease.
Amantadine: Symptoms of Amantadine toxicity.
Ataxia, dizziness, slurred speech. (Rimantidine is a derivative with fewer
CNS side effects.)
Zanamivir: Mechanism of action of Zanamivir.
Inhibits influenza neuraminidase.
Zanamivir: Clinical use of Zanamivir.
Both influenza A and B.
Ribavirin: Mechanism of action of Ribavirin.
Inhibits synthesis of guanine nucleotides by competitively inhibiting IMP
dehydrogenase.
Ribavirin: Clinical use of Ribavirin.
RSV (respiratory syncytial virus).
Ribavirin: Symptoms of Ribavirin toxicity.
Hemolytic anemia. Severe teratogen.
Acyclovir: Mechanism of aciton of Acyclovir.
Perferentially inhibits viral DNA polymerase when phosphorylated by viral
thymidine kinase.
Acyclovir: Clinical use of Acyclovir.
HSV, VZV, EBV. Mucocutaneous and genital herpes lesions. Prophylaxis in
immunocompromised patients.
Acyclovir: Symptoms of Acyclovir toxicity.
Delirium, tremor, nephrotoxicity.
Ganciclovir (DHPG dihydroxy-2-propoxymethyl guanine): Mechanism of
action of Ganciclovir.
Phosphorlation by viral kinase; perferentially inhibits CMV DNA
polymerase.
Ganciclovir (DHPG dihydroxy-2-propoxymethyl guanine): Clinical use of
Ganciclovir.
CMV, especially in immunocompromised patients.
Ganciclovir (DHPG dihydroxy-2-propoxymethyl guanine): Symptoms of
Ganciclovir toxicity.
Leukopenia, neutropenia, thrombocytopenia, renal toxicity. More toxic to
host enzymes than acyclovir.
Foscarnet: Mechanism of action of Foscarnet.
Viral DNA polymerase inhibitor that binds to the pyrophophate binding site
of the enzyme. Does not require activation by viral kinase. "FOScarnet =
pyroFOSphate analog."
Foscarnet: Clinical use of Foscarnet.
CMV retinitis in immunocompromised patients when ganciclovir fails.
Foscarnet: Symptoms of Foscarnet toxicity.
Nephrotoxicity.
HIV therapy: Saquinavir, ritonavir, indinavir, nelfinavir, amprenavir are
example of this type of anti-HIV drug.
Protease inhibitor.
HIV therapy: Mechanism of action of protease inhibitors.
Inhibit assembly of new virus by blocking protease enzyme.
HIV therapy: Symptoms of protease inhibitor toxicity.
GI intolerance (nausea, diarrhea), hyperglycemia, lipid abnormalities,
thrombocytopenia (indinavir).